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Mechanisms for cellular uptake of nanoparticles have important implications for nanoparticulate drug delivery and
toxicity. We have explored the mechanism of uptake of amorphous silica nanoparticles of 14 nm diameter, which
agglomerate in culture medium to hydrodynamic diameters around 500 nm. In HT29, HaCat and A549 cells,
cytotoxicity was observed at nanoparticle concentrations ≥ 1 μg/ml, but DNA damage was evident at 0.1 μg/ml
and above. Transmission electron microscopy (TEM) combined with energy-dispersive X-ray spectroscopy confirmed
entry of the silica particles into A549 cells exposed to 10 μg/ml of nanoparticles. The particles were observed in the
cytoplasm but not within membrane bound vesicles or in the nucleus. TEM of cells exposed to nanoparticles at
4°C for 30 minutes showed particles enter cells when activity is low, suggesting a passive mode of entry. Plasma
lipid membrane models identified physical interactions between the membrane and the silica NPs. Quartz crystal
microbalance experiments on tethered bilayer lipid membrane systems show that the nanoparticles strongly bind
to lipid membranes, forming an adherent monolayer on the membrane. Leakage assays on large unilamellar
vesicles (400 nm diameter) indicate that binding of the silica NPs transiently disrupts the vesicles which rapidly
self-seal. We suggest that an adhesive interaction between silica nanoparticles and lipid membranes could cause
passive cellular uptake of the particles.
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The unique physicochemical properties of nanoparticles
(NPs) that have given rise to applications in many fields,
including drug delivery [1], cancer therapy [2], biosen-
sors [3], food additives and cosmetics [4], may also in-
crease the risk of toxicity to humans or the environment
[5]. Many in vitro studies have demonstrated that certain
NPs are cytotoxic and can cause oxidative stress and
DNA damage, which has raised human health concerns
[5-10]. As more NPs and NP-containing products are
developed and brought into commercial use, it is gener-
ally assumed that NPs will enter the environment [11].* Correspondence: A.P.Brown@leeds.ac.uk; L.J.C.Jeuken@leeds.ac.uk;
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reproduction in any medium, provided the orIndustrial production of NPs is increasing in scale and
diversity, raising additional concerns of environmental
exposure to nanomaterials. The potential for human and
ecological toxicity associated with nanomaterials is thus
a growing area of investigation [12]. The toxic effects of
a wide range of sizes of silica NPs have been tested
and despite the NPs showing fast agglomeration upon
contact with cell culture media, smaller sized silica
NPs have been shown to be more cytotoxic than larger
ones, [13,14].
It is critical to understand fundamental mechanisms
underlying any biological responses to NPs, be they de-
sirable or not. Understanding the principles of how NPs
can transmigrate into cells could enable greater control
over cellular uptake and would improve prediction of
possible toxic effects. There have been reports that some
NPs are taken up by cells via non-endocytic pathways
[11,15,16], and model membranes have indicated pos-
sible mechanisms for non-endocytic uptake [17-19]. For
instance, Banerji et al. showed that citrate-capped gold. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 (a) Dynamic light scattering measurements of silica
NP (100 μg/ml) size distributions in MilliQ water (solid line) and
DMEM (dashed line) at 37°C. (b,c) TEM images of silica NPs
(100 μg/ml) suspended in (b) Milli-Q water and (c) DMEM. Due to
the relatively low electron density of SiO2 the TEM images of the
dispersed silica NPs have low contrast (b) so for clarity, three isolated
NPs are identified with arrows.
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lipid membrane and can be encapsulated by vesicles
[18]. In contrast, hydrophobic alkane-thiol coated gold
NPs of 2 nm diameter become located inside the hydro-
phobic core of the lipid bilayer (whereas larger hydro-
phobic particles tend to disrupt lipid vesicles) [19]. A
range of behaviours has been observed with amorphous
silica particles. Particles up to 5 μm diameter have been
shown to enter the cytoplasm of cells and although they
are considered to have good biocompatibility, they have
been shown to have haemolytic activity (see [20] and
references therein). Mesoporous silica NPs cause
haemolysis of mammalian red blood cells through inter-
action between the surface of the NPs with the cell
membrane [20-22]. Silica NPs of less than 100 nm can
induce endocytosis-dependent reactive oxygen species
generation, DNA damage [23] and aberrant nucleoplas-
mic protein aggregation [24,25]. Furthermore, amorph-
ous silica particles of 15–20 nm can bind to lipid
vesicles, while larger particles (up to 190 nm) can trans-
migrate into giant unilamellar vesicles (GUV) [17]. In
the latter case the silica particles were coated with a lipid
membrane in the process. Membrane disruption by
amorphous silica nanoparticles has also been identified
by electrophysiological methods [26]. If such disruption
were to enable uptake directly into the cytoplasm,
without significant damage to the cell, silica nanoparti-
cles would be potential vehicles for drug delivery
applications. The biocompatibility of amorphous silica,
its amenability to surface modification and the fact
that it is not electro-active in aqueous media has
already led others to consider it for application in gene
and drug delivery [27,28].
The affinity of amorphous silica for lipid bilayers and
the potential for ‘passive’ uptake in vesicles makes silica
NPs an intriguing target for toxicological as well as
drug-delivery studies. The objectives of this study were
to explore the mechanism by which amorphous silica
NPs (of 14 nm diameter) enter the cell and to evaluate
in vitro cytotoxicity and the potential to induce DNA
damage of the NPs. Dynamic Light Scattering (DLS) was
used to identify agglomeration in the cell culture
medium and transmission electron microscopy (TEM)
was used to identify cellular uptake of the silica NPs.
Biomembrane models were used to study the interaction
with lipid membranes, to establish whether the silica
NPs can induce structural changes to a phospholipid bi-
layer, thereby compromising the barrier function of the
plasma membrane and inducing uptake.
Results
Dispersion in cell culture medium
The size distribution of silica NPs at 37°C was deter-
mined by dynamic light scattering. In ultra-pure water(MilliQ, 18 MΩcm), the NPs were monodispersed with
a dominant volume fraction around 14 nm (Figure 1a)
and this was confirmed by TEM (Figure 1b). Suspended
in Dulbecco’s Modified Eagle’s Medium (DMEM), how-
ever, the NP dispersion showed a dominant volume frac-
tion at about 500 nm (Figure 1a), indicating that the
particles significantly agglomerate or aggregate in this
growth medium. Similar agglomeration was also
observed in MOPS buffer (20 mM MOPS, pH 7.4,
30 mM Na2SO4) and phosphate-buffered saline (PBS)
solution, indicating a general effect due to the ionic
strength of the medium. The tendency to aggregate or
agglomerate in DMEM was also confirmed by TEM
(Figure 1c).
Cyto- and genotoxicity
Cytotoxicity was tested on three epithelial cell lines that
were treated with varying doses of silica NPs for
24 hours. Cell viability determined by the MTT assay
reduced significantly at a dose of 100 μg/ml and above
(Figure 2a). In most cases, the HaCat cells exhibited
increased resistance towards the silica NPs, compared to
the other two cell lines.
Figure 2 (a) Viability of A549, HaCat and HT29 cells
incubated with silica NPs for 24 hrs as determined by the
MTT assay. * and ** indicate that the viability is significantly lower
than the control with p< 0.05 and p< 0.01, respectively. (b) DNA
strand breaks induced by silica NP incubation for 24 hrs as
determined by the Comet assay. * and ** indicate that the DNA tail
is significantly longer than the control with p< 0.05 and p< 0.01,
respectively.
Figure 3 (a) TEM image of an A549 cell after incubation with
10 μg/ml silica NPs for 24 hrs at 37°C. (b) Higher magnification
image of the area indicated by the box in (a). (c) TEM image of A549
cells after incubation with 100 μg/ml silica NPs for 24 hrs at 37°C,
showing a corner of one of the few remaining cells and surrounding
it a large amount of cell debris, which was predominant throughout
the sections. (d) EDX spectrum from the silica NP containing region
of the A549 cell shown in (b).
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Comet assay, also called single cell gel electrophoresis,
which determines a combination of single-strand breaks
and alkaline labile sites in individual cells [29]. Based on
the cytotoxicity results, the three cell lines were treated
with silica NPs at concentrations up to 10 μg/ml (signifi-
cant cell death at higher concentrations hampers the in-
terpretation of the assay results). The results (Figure 2b)
show a significant increase in DNA damage compared
to controls at concentrations of 1 and 10 μg/ml. Consist-
ent with the results of the cytotoxicity assay, the HaCat
cell line was the most resistant to DNA damage when
incubated with 10 μg/ml silica.TEM results
In order to determine whether the silica NPs are taken
up by the cells, and if they are, where the NPs localise
within the cell, TEM images were recorded for A549
cells incubated with 10 μg/ml and 100 μg/ml silica for
24 hours under identical conditions as the MTT and
Comet assays. TEM of the cells incubated with 10 μg/ml
silica showed that the majority of cells were intact and
that silica NPs were present in the cytoplasm (Figure 3a,
3b). There was not much cell debris observed by TEM
at this concentration. Due to the small size of the NPs
and the low electron density of SiO2, energy-dispersive
X-ray spectroscopy (EDX) was required to confirm
that the particles in Figure 3b were indeed silica
(Figure 3d). The particles were well dispersed or only
loosely agglomerated in parts of the cell. Since conven-
tional heavy metal staining masks the location of the
NPs and they could only be detected in unstained sec-
tions, the precise cellular localisation of the particles
was not easy to determine. However, the nucleus can
be identified in the unstained sections (because the os-
mium tetroxide fixative lightly stains lipids) and the
images consistently indicated that the silica NPs were
not present in the nucleus (Figure 3a). Furthermore, we
Figure 4 (a) TEM image of A549 cellular uptake of silica NPs
after incubation with 100 μg/ml for 30 mins at 4°C. (b) Higher
magnification image of the area indicated by the box in (a). (c) EDX
spectrum from the silica NP containing region of the A549 cell
indicated by the box in (b).
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endosomes. Further TEM images are available in
Additional files 1, 2, 3, 4, 5 and 6.
To confirm that the apparent location of the silica par-
ticles was not due to an artefact of the sectioning of the
resin-embedded cell samples, specimen tilt series were
recorded for Figure 3a and 3b (Additional files 7 and 8,
respectively). Analysis of the tilt series confirmed that
the silica NPs were located in the TEM section (rather
than on top of the section) and were in the cytoplasm
with no apparent membrane encapsulation.
Finally, from the TEM images it was also obvious that
a higher silica dosage (100 μg/ml) caused significant cell
death. Figure 3c shows part of one of the very few intact
cells that were observed in the TEM sections and the
large amount of cell debris around the cell, possibly
mixed with the NPs. The low number of intact cells is
consistent with the cytotoxicity results.
Internalization of NPs into the cell types tested here
usually takes place by endocytosis [30-32], but some
reports have emerged in which non-endocytic pathways
are proposed [11,15,16]. To explore cellular uptake
mechanisms of silica NPs by A549 cells, particle expos-
ure was carried out for 30 min incubation at 37°C and
4°C. TEM-EDX was again used to confirm the presence
of silica NPs inside the cells (Figure 4 and Additional
files 3, 4, 5 and 6). The cells incubated with 100 μg/ml
silica NPs at 37°C for 30 min showed a similar uptake of
NPs as those incubated with 10 μg/ml silica NPs at the
same temperature for 24 hours. Importantly, the cells
incubated at 4°C, at which temperature active cell pro-
cesses are significantly suppressed, also showed NP up-
take and, again, the NPs themselves were spread out in
the cytoplasm without obvious membrane encapsulation
(Figure 4). Furthermore, at 4°C the cellular membrane
seems to be densely covered with NPs, although there is
no evidence of structural damage to the membranes.
The ‘wavy’ structure of the cell edge was also found in
the control cells incubated at 4°C and is thus likely to be
a temperature effect (Additional file 4).Model membranes
At concentrations of NPs ≥ 100 μg/ml, MTT assays and
TEM indicated that the cells are not viable and undergo
lysis. Below 100 μg/ml, TEM analysis leads to the sug-
gestion that the silica NPs were taken up via a non-
endocytic pathway. In order to test if both effects could
be due to a strong interaction between the particles and
the plasma membrane, resulting in the physical break-
down of the membrane, the interaction of the NPs with
various model membranes was studied. The binding of
NPs and breakdown of model membranes was studied
using a tethered bilayer lipid membrane (tBLM) system.In the tBLM system, a lipid bilayer is attached to a metal
electrode in a planar orientation (Figure 5a).
The formation of the lipid bilayer in the tBLM system
and the binding of particles to the lipid membrane can
be monitored by Quartz-Crystal Microbalance with Dis-
sipation (QCM-D). In Figure 5b, the formation of the
tBLM is not shown for clarity. The oscillation frequency
of around -20 Hz at the beginning of the trace is due to
the mass of the lipids in the tBLM. Upon addition of
10 μg/ml silica NPs, a very strong decrease in frequency
was observed indicating that the NPs bind to the surface
of the membrane. At the same time, the dissipation of
the oscillation only rose by around three units, indicative
of a tight interaction between rigid NPs and the lipid
membrane. This is further supported by the fact that
rinsing the system did not change the frequency or dissi-
pation, suggesting that rinsing does not release the NPs
from the membrane (Figure 5b). A further addition of
100 μg/ml did not induce a large change in the QCM-D
response, indicating that the lipid membrane was already
Figure 5 (a) Schematic of the tBLM system used in (b) and (c).
A gold surface is modified with a mixed self-assembled monolayer
containing cholesterol groups. The surface is then incubated with
vesicles made up of Lipid Mix 1 (POPC:DOPS:cholesterol at 15:1:4
weight ratio), which assembles into a planar membrane across the
gold surface, (b) QCM-D plots of a tBLM in DMEM after additions of
10 and 100 μg/ml of silica NPs (dispersed in DMEM) and after
washes with DMEM at times indicated by the arrows. (c) Impedance
spectra plots (normalised admittance) of a tBLM in DMEM before
and after incubation with 10 and 100 μg/ml of silica NPs at 21°C for
the indicated time.
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calculated that 2.1 μg/cm2 silica NPs bind onto the
tBLM layer after addition of 100 μg/ml in solution. A
fully-packed hexagonal arrangement of a monolayer of
14-nm silica NPs (density 2.648 g/cm3) has an areal
mass of 2.24 μg/cm2. When the data is analysed using a
Voigt model that assumes two layers (a fixed layer forthe tBLM and a second layer for the silica), a silica layer
thickness of 17.6 nm is obtained, again consistent with a
well packed monolayer of 14-nm silica NPs on the lipid
membrane. This dispersion across the membrane indi-
cates that the silica NP agglomeration, which occurs
upon dispersion in DMEM (Figure 1), can be broken
down and as such is not aggregation.
It is possible that the tightly-bound NPs physically
damage the plasma membrane, potentially permeabilis-
ing it to polar compounds and NPs. To study this
proposition, the tBLM was characterised using electro-
chemical impedance spectroscopy (EIS), which is sensi-
tive to ion transport through a membrane. The tBLM is
unperturbed by the addition of NPs up to 100 μg/ml
(Figure 5c), suggesting that the plasma membrane
remains a constructive barrier upon binding of silica
NPs. We note, however, that EIS is insensitive to rare,
dynamic perturbations of the membrane. To study
whether silica NPs can enter cells by transient mem-
brane disruption, vesicle-leakage assays were performed.
400-nm diameter vesicles of various lipid compositions
were loaded with an auto-quenching fluorescent dye and
incubated with the NPs. Release of the dye from a vesicle
results in a dilute concentration in solution and thus
raises the observed fluorescence intensity. Indeed, sig-
nificant fluorescence increases were observed upon
addition of NPs, indicating some dye is released and the
lipid membrane is compromised (Figure 6a). The real
time fluorescence data is quantified in Figure 6b. Up to
20% of the dye was observed to be released by the vesi-
cles upon addition of 100 μg/ml NPs. It is also notice-
able that more significant effects were found in MOPS
buffer than in DMEM (Figure 6b). We note that the lipid
content in fluorescent leakage assays was 15 μg/ml and
that the number of NPs far exceeded the number of
vesicles in solution. At 100 μg/ml, enough silica NPs
were present to fully cover the lipid vesicles, but at
10 μg/ml NPs it is estimated that only a submonolayer
can be formed.Discussion
It is recognised that the potential dose of silica particles
depends on mass concentration, particle number or sur-
face area. It has been noted previously that silica NPs
show fast agglomeration and some dissolution upon
contact with cell culture media, which directly influences
the uptake into the cell [13,21]. We have used well char-
acterised amorphous silica NPs of 14 nm diameter to ex-
plore the interaction of sub-lethal concentrations of NPs
with cultured A549, HT29 and HaCat cells. We found
that the particles aggregated or agglomerated in DMEM
culture medium to form assemblies of NPs around 500 nm
(Figure 1). Previous results have indicated that larger
Figure 6 (a) Fluorescence intensity of carboxyfluorescein-
loaded vesicles in 20 mM MOPS, 30 mM Na2SO4, pH 7.4 after
the addition of 10 and 100 μg/ml of silica NPs and 0.1% (v/v)
Triton X-100, at times indicated by the arrows. The vesicles are
made up of Lipid mix 1 (POPC:DOPE:DOPS:cholesterol at 9:6:1:4
weight ratio) and loaded with 50 mM carbofluorescein. (b) Leakage
of carboxyfluorescein from 400 nm vesicles after the addition of
silica NPs under various conditions, as indicated (MOPS= 20 mM
MOPS, 30 mM Na2SO4, pH 7.4; DMEM=Dulbecco’s Modified Eagle’s
medium; Lipid Mix 1 = POPC:DOPS:cholesterol at15:1:4 weight ratio;
Lipid Mix 2 = POPC:DOPE:DOPS:cholesterol at 9:6:1:4 weight ratio).
Leakage (as a percentage) was determined assuming 0% leakage
prior to addition of NPs and 100% leakage after the addition of 0.1%
(v/v) Triton X-100 as shown in (a).
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than smaller particles [20,33]. Here, nearly all cells lysed
after 24 h exposure to a NP concentration of 100 μg/ml
(Figure 2), consistent with previous findings for amorphous
silica NPs below 100 nm diameter exposed for A549 cells
[34] and several other cell types [13,14,23,35-37] exposed
to amorphous silica NPs below 100 nm diamter.
Silica NPs have been shown to induce caspase activa-
tion and cell death by apoptosis, however, the pathway
leading to apoptosis is controversial [38-40]. It has been
suggested by Wittmaack [41,42] that in vitro cytotoxicity
due to silica and other NPs is strongly influenced by
gravitational settling of the particles forming highconcentrations on top of the cells in the cultures and it
is this ‘coating’ which then interferes with membrane
mediated processes. In our experiments, TEM of cells
exposed for 24 h to 100 μg/ml silica NPs showed that
nearly all cells had already lysed, with large clumps of
silica particles visible in the debris (Figure 3c).
Previous studies do not report a consistent threshold
dose of amorphous silica NPs above which genotoxicity
is detectable (see ref. [13] for an extensive review on sil-
ica toxicity). Up to 40 μg/ml silica NPs did not induce
genotoxicity in fibroblast cells in a comparative study in
which three laboratories carried out the Comet assay
[43]. In contrast, in this study, significant DNA damage
was observed in the Comet assay in three different cell
lines at only 10 μg/ml, at which dose silica particles were
found inside the cytoplasm of A549 cells, but not in the
nucleus (Figures 2 and 3). In our study the NP dosing
for the Comet assay was undertaken in serum-free
DMEM whereas Barnes et al. dosed in DMEM supple-
mented with 10% foetal bovine serum (FBS) [43]. Serum
proteins have been shown to interact with silica NPs
[36] with serum concentration reducing the amount of
cellular uptake of iron oxide nanoparticles and therefore
the biological impact of exposure, particularly where
genotoxicity assays are concerned [44].
It has previously been reported that reactive oxygen
species (ROS) are responsible for toxic effects from crys-
talline silica NPs [13,45] and that ROS are induced in
cells that have taken up amorphous silica, leading to
cytotoxicity [46] and genotoxicity [23]. The absence of
particles in the nucleus suggests that the DNA damage
is due to a cellular response to the presence of particles
inside the cell. Here the particles inside the cytoplasm
do not appear to be associated with or encapsulated by
internal membrane systems although with the current
TEM specimen preparation of only 1% osmium tetroxide
fixative and no additional heavy metal stains it is difficult
to prove this (Figures 3 and 4). However, endocytic up-
take of iron oxide NPs and carbon nanotubes has been
readily identified for other cells types that have been
prepared for TEM in a similar manner [47,48]. More im-
portantly, non-membrane bound uptake of amorphous
silica NPs (43 nm diameter) has previously been identi-
fied by TEM, alongside uptake in endocytic vesicles, in a
hepatocellular carcinoma (HepG2) cell line exposed in
serum-free culture media [49]. This contrasts with most
previous studies that have shown silica NPs delivered in
cell culture media supplemented with serum proteins,
tend to be taken up by endocytosis and, in general, to be
associated with internal membranes once inside the cell
[50,51]. The TEM results here suggest that a non-
endocytic pathway is in operation in addition to the
expected (endocytic) routes. The experiments performed
at 4°C indicate that active cellular processes are not
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(Figure 4). Uptake of silica NPs in red blood cells (RBC),
which do not carry out active endocytotic uptake, has
already been demonstrated [20-22] and recently it has
been shown that zwitterionic quantum dots can pas-
sively cross the cell membrane of erythrocytes [52].
In addition, amorphous silica particles can cross lipid
bilayers and enter giant unilamellar vesicles (GUV), al-
though particles smaller than 20 nm apparently only
bind to and do not enter the lipid vesicles [17]. The sil-
ica NPs in our study form 500 nm agglomerates in the
cell culture medium (Figure 1) and our QCM-D studies
suggest that these agglomerates can disperse on contact
with the membrane to form a densely packed silica
monolayer coating (Figure 5b). The electrochemical im-
pedance spectroscopy, however, is not affected by the
addition of silica particles (up to a dose of 100 μg/ml),
indicating that 14 nm silica particles are not able to
structurally impair the lipid membrane (Figure 5c). This
would suggest that these silica NPs only bind to lipid
vesicles and cells without further penetration, which
differs from previous results that showed disruption of
membranes by bound silica nanospheres covering less
than 1% of the surface of a lipid bilayer [26]. However,
our dye leakage experiments clearly indicate that lipo-
somes, composed of lipid mixtures typical of cellular
plasma membranes, are transiently, structurally dis-
rupted immediately after mixing with the silica NPs
(Figure 6). Previous studies show that there is a size
dependent response to RBC membrane disruption by
silica NPs and so the agglomeration or aggregation of
the silica NPs in our study might still be important
[22]. A model could be proposed in which leakage is
induced by the lipid membrane wrapping or bending
around the silica agglomerates before they can disperse
across the membrane. The reduced curvature around
large agglomerates could be required to accommodate
the limited bending capacity of the lipid membrane.
This model is consistent with the absence of a response
of the tethered bilayer system (Figure 5), which is hin-
dered from bending because it is tethered to a planar
surface.
An alternative model might operate where the silica
NP agglomerates fully disperse across the vesicle mem-
brane, (as per the tethered bilayer measurement; Figure 5)
and the consequent coverage of vesicles induces a strain
that is released by transient pore formation. Significantly,
in our study only part of the dye is released upon addition
of NPs and the disruption of the vesicles is only observed
for a very short time after NP addition. This indicates that
the membrane disruption upon the addition of silica NPs
is transient and the resulting pores reseal rapidly, also
consistent with the absence of effects in the impedance
spectra (Figure 5). Considerable leakage is only observedat 100 μg/ml, while much less leakage is observed at
10 μg/ml (Figure 6). It is striking that only at 100 μg/ml
there are sufficient numbers of silica NPs to fully coat the
400 nm lipid vesicles in this leakage assay, suggesting that
a full monolayer of silica particles might indeed be
required to induce leakage. Previous studies using bile
salts have suggested that asymmetric binding to the lipid
membrane of vesicles can induce strain, resulting in tran-
sient membrane pores which release this strain [53]. The
disrupting effect of bile salts was dependent on the lipid
composition as well as on chemical additions to the buffer
(e.g. glycine). Here, an influence of both lipid and buffer
composition is also observed. In fact, certain lipid
compositions such as total sheep brain lipid extracts are
unperturbed by silica NP in the dye-release assay (data
not shown).
Recently, confocal microscopy studies were performed
on DOPC giant unilamellar vesicles (GUVs) exposed to
1–100 μg/ml of silica NPs at physiological pH for
20 minutes, which confirm the formation of stable,
micrometre-size pores and unusual crinkles in the GUVs
[54]. The formation of pores and crinkles has been
attributed to the significant reduction in lateral lipid mo-
bility and lipid free volume after the adsorption of NPs
onto the lipid membrane. We hypothesise that a similar
mechanism operates at the plasma membrane of the cell;
doses of 10 μg/ml silica NPs induce the formation of
transient pores to allow uptake of the NPs into the cells.
The exact mechanism of cell death at higher doses could
be due to (a) increased amounts of NP uptake and the
cell’s response to the particles in the cytoplasm, (b)
increased amounts of transient pores breaking down the
plasma membrane or (c) effects that silica NPs exert on
the plasma membrane upon binding, such as changing
its fluidity or impairing membrane protein function.
Conclusion
We show that for a range of cell types, amorphous silica
NPs, 14 nm in diameter but agglomerated to 500 nm in
cell culture medium, cause reduced cell viability and can
induce DNA damage. The precise impact of serum pro-
teins in the cell growth media on particle agglomeration,
uptake and toxicity is still to be determined. We suggest
that for A549 cells, exposure in the absence of serum
proteins results in silica NP uptake to the cytoplasm dir-
ectly. Tethered model membrane experiments indicate
that the NPs bind to membranes to form a densely-
packed monolayer without significant membrane disrup-
tion, while for unilamellar vesicles the NPs induce
transient membrane disruption. This adhesive inter-
action with lipid membranes suggests amorphous silica
NPs can be passively transported into cells. These data
also indicate that silica NPs are unlikely to have signifi-
cant human health effects at environmental exposure
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still to be determined. The particles might thus be a suit-
able vehicle for drug delivery and gene therapy.
Methods
Materials and NP characterisation
All chemicals were purchased from Sigma (UK) unless
stated otherwise. Mercapto-ethyleneoxy3-cholesterol (EO3C)
was synthesised as previously described [55].
The amorphous silica NPs (Ludox SM-30) used in this
study were purchased from Ludox Colloid Silica and dia-
lysed for three days against MilliQ water (18 MΩ cm).
Nanoparticle dispersions were diluted in MilliQ water
and DMEM at 100 μg/ml for subsequent characterisa-
tion after leaving the dispersions to stabilise for at least
24 hours. ICP-MS (Perkin Elmer Elan DRC-e) of a
10 μg/ml silica sample in MilliQ water did not detect
any transition metals in the sample. Dynamic light scat-
tering (DLS) of NP dispersions were conducted at 37°C
using a Malvern Zetasizer Nano ZS and the Zetasizer
software (Version 6.20). Each dispersion was analysed 3
times with the average result presented. Transmission
electron microscopy (TEM) of the NP dispersions was
conducted on an FEI Tecnai F20 FEG-TEM operating at
200 kV equipped with a Gatan Orius SC600A CCD
camera. TEM samples were prepared by plunge-freezing:
a 3.5 μL droplet of each dispersion was placed on a glow
discharge treated carbon support film (R1.2/1.3 Quanti-
foil MicroTools GmBH), blotted and plunge frozen in li-
quid ethane [56]. The grids were then warmed under
vacuum to devitrify and sublime the ice prior to imaging
in the TEM.
Cell culture
A549 (human lung alveolar carcinoma) cells and HT29
(human colon cancer) cells were cultured in DMEM
containing 10% foetal bovine serum (Lonza, Slough, UK)
with 0.5% penicillin streptomycin. HaCat (human kera-
tinocyte) cells were cultured in RPMI media (Gibco,
Paisley, Scotland) containing 10% foetal bovine serum
(Lonza, Slough, UK) with 0.5% penicillin streptomycin.
All cell lines were incubated at 37°C in humidified 5%
CO2 until they were approaching confluence when they
were harvested using 10% trypsin-ethylene diamine
tetra-acetic acid (EDTA) and then re-seeded.
MTT assay
Effects of silica NPs on the viability of A549, HT29 and
HaCat cells were evaluated using the MTT assay (thiazo-
lyl blue tetrazolium bromide). Cells were seeded in a 96
well plate (Fisher) at a density of 20,000 cells/well in
DMEM with 10% fetal bovine serum and allowed to at-
tach overnight at 37°C with 5% CO2. After removing the
culture medium by two washes with phosphate bufferedsaline (PBS), the toxicity assay was started with 225 μL
serum-free DMEM with specified amounts of silica
(0–1000 μg/ml) for 24 hours. The MTT assay was per-
formed according to the manufacturer’s protocol
(Sigma). Optical absorbance was read using a Labsys-
tems iEMS Reader MF at 540 nm. The results are
expressed as percentage viability compared with un-
treated controls.
Comet assay
A549, HT29 and HaCat cells were plated at a density of
120,000 cells/well in 24-well plates (Fisher) in medium
overnight, after which they were incubated with silica
NPs in serum free DMEM for 24 hrs at 37°C with 5%
CO2. The cells were pelleted by centrifugation at
1000 rpm for 5 min and resuspended in serum-free
DMEM to a concentration of 1x106 cells/ml. A 100 μL
aliquot of this suspension was mixed with 200 μL of 1%
(w/v) low-melting-point agarose in phosphate buffered
saline (PBS) solution and kept at 37°C until use. 100 μL
was placed onto duplicate microscope slides (Thermo
Scientific) pre-coated with 1% (w/v) low-melting-point
agarose and covered with a coverslip (Scientific Labora-
tory Supplies Ltd.). Slides were placed on ice to allow
the agarose to solidify, after which the coverslips were
removed. The slides were treated with a detergent lysis
solution (2.5 M NaCl, 1 mM EDTA, 10 mM Tris, 10%
DMSO, 1% Triton X-100 at pH 10) for 1 hour and
placed in running buffer (300 mM NaOH, 1 mM EDTA
at pH 13) at 4°C for 40 min to allow DNA unwinding,
followed by electrophoresis at a constant voltage of 23 V
for 20 min. Slides were finally removed, neutralised by
adding 400 mM Tris at pH 7.5 for 5 min, gently dried
and stained with 30 μL ethidium bromide (25 μg/ml).
Coverslips were placed onto each gel and the stained
slides were stored in damp conditions at 4°C. The slides
were viewed using an Olympus BX41 microscope and
digitally analysed using Komet 5.5 software. Cells were
scored by evaluating 50 cells per slide, with duplicate
slides for every sample.
TEM sample preparation
Cell culture sample preparation for TEM was identical
to that used in the Comet assay. After incubation with
silica NPs, cells were trypsinized, harvested by centrifu-
gation at 1000 rpm for 5 min and kept on ice until use.
The preparation of 4°C samples followed the same cell
culture procedure as the 37°C samples except these were
incubated with silica NPs at 4°C for 30 min. In both
cases, the cell pellet was fixed with 2.5% glutaraldehyde
in PBS for 2.5 hours, followed by two 30 min PBS
washes. Osmium tetroxide, 1.0% (w/v), was added to the
fixed cells and allowed to incubate for 16 hours. After
another two 30 min PBS washes the cell sample was
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100% with 20% step increases for 30 min each time. In
order to embed the cells, the sample was washed with
propylene oxide twice for 20 min, then incubated in pro-
pylene oxide and araldite (1:1) for 16 hours, followed by
transfer to propylene oxide and araldite (1:3) for several
hours and finally transfer into pure araldite for 8 hours.
The cells were transferred to embedding moulds con-
taining fresh araldite, which was then polymerised for 16
hours at 60°C. The region of interest was cut off and
glued onto a blank flat-end beam capsule using super
glue and baked dry for 1 hour, before trimming and cut-
ting ultrathin sections of 60 nm thickness with an ultra-
microtome and diamond knife.
TEM was conducted on two microscopes; an FEI
CM200 field emission gun (FEG-)TEM running at
197 kV equipped with an Oxford Instruments energy
dispersive X-ray (EDX) spectrometer and a Gatan Im-
aging Filter (GIF-200) and an FEI Tecnai F20 FEG TEM
operating at 200 kV fitted with a Gatan Orius SC600A
camera and an Oxford Instruments energy dispersive
X-ray (EDX) spectrometer. The tilt series was collected
through a tilt range of +46 to −46 degrees with an image
recorded every one degree on the Gatan Orius SC600A
camera and processed using the software ImageJ [57],
with the TomoJ plugin [58]. Images in the tilt series
were defocused (underfocus) by 180 μm from minimum
contrast to enhance the contrast of the amorphous NPs
in the unstained cell section.
Model membrane studies
The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line (POPC), 1,2-dioleoyl-sn-glycero-3-phospho-L-serine
(sodium salt, DOPS), 1,2-dioleoyl-sn-glycero-3-phos-
phoethanolamine (DOPE) and cholesterol (ovine wool)
were purchased from Avanti Polar Lipids (Alabaster, AL)
(all lipids at purity> 99%). Two liposome mixtures were
prepared: Lipid Mix 1 (POPC:DOPS:cholesterol at 15:1:4
weight ratio) and Lipid Mix 2 (POPC:DOPE:DOPS:chol-
esterol at 9:6:1:4 weight ratio). The lipid mixtures were
prepared by mixing solutions of the pure lipids (dissolved
in (1:1) methanol/chloroform), fractioned in 5 mg total
lipid aliquots in glass vials and dried under vacuum for at
least 2 hours. Aliquots of lipid mixtures were stored
under nitrogen at −20°C until use. Vesicles were prepared
by dispersing 5 mg/ml lipid in MOPS buffer (20 mM 3-
(N-morpholino)propanesulfonic acid, 30 mM Na2SO4,
pH 7.4) by vortexing and tip sonicating (Branson Sonica-
tor 250) at 4°C for 25 min. Titanium particles from the
tip were removed by spinning at 14,500 × g for 4 min.
Impedance spectroscopy of tethered bilayer lipid mem-
branes (tBLMs): The preparation of the tBLMs xon
template-stripped gold electrodes and the characterisation
with electrochemical impedance spectroscopy (EIS) wereperformed in MOPS buffer, as described previously
[59]. After replacing the MOPS buffer with DMEM
solution, 10 μg/ml and/or 100 μg/ml silica NPs were
added and the impedance monitored for the time
indicated in the results section. All experiments were
run at 20oC. Controls were recorded in the absence
of silica NPs.
Quartz-crystal microbalance with dissipation (QCM-D):
QCM-D experiments were performed on a QSense E4
(Gothenburg, Sweden). Gold coated quartz crystals were
cleaned by sonicating them in 10% Decon in a water bath,
rinsing with Milli-Q water, drying under a flow of nitrogen
and then exposing them to a UV-Ozone cleaner (UVOCS
Inc.) for 15 min and finally by incubating them in distil-
ling ethanol (Soxhlet extractor) for another 30 min.
tBLMs were formed on the gold-coated crystals in
MOPS buffer, as described previously [59]. All QCM-D
experiments were conducted under a flow rate of 100
μL/min at 21°C. Changes in the dissipation, ΔD, and
normalized frequency, Δf (f= fn/n, where n is the num-
ber of the overtone, i.e., n = 3, 5, 7, etc.) of the ninth
overtone (n= 9, 45 MHz) are presented in this work.
Due to the mass of the lipids that form the tBLM on
the QCM-D crystals, the traces in the result section start
at about −20 Hz (the QCM-D responses to the forma-
tion of the tBLMs are not shown). After exchanging the
buffer solution with DMEM, silica NPs (10 μg/ml) were
introduced to the tBLM until no further changes in fre-
quency or dissipation were observed, followed by a
DMEM wash. Finally, silica at a concentration of
100 μg/ml was introduced. Control experiments were
made without silica NPs. The data was analysed using
the QSense software, Qtools.
Leakage assays: Carboxyfluorescein (CF)-encapsulated
vesicles were prepared as described above for lipid
vesicles, except that the lipid was resuspended in 1 ml
of CF solution (50 mM) in MOPS buffer, vortexed and
extruded through track-etched membranes (400 nm)
using an Avanti extruder. Non-encapsulated CF was
removed by size-exclusion chromatography with Sepha-
dex G-25 (NAP-5 columns, GE Healthcare). Leakage of
CF out of the vesicles as a function of time was moni-
tored at 21°C by fluorescence with excitation at
492 nm and emission at 517 nm. The CF-loaded lipid
vesicles were diluted at least a 100 times in either
MOPS buffer or DMEM and equilibrated at room
temperature for 3 hours. Fluorescence time scans were
taken with a Perkin Elmer Lambda 35 spectrofluoro-
photometer. After monitoring the sample for 10 min,
silica NPs were added at the indicated concentration
and the fluorescence intensity recorded over time. A
complete release of CF from the vesicles was achieved
at the end of the experiment by adding 0.1% Triton
X-100 to lyse the vesicles.
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Additional file 1: TEM bright field images of an A549 cell after 24 h
incubation at 37°C with 10 μg/ml amorphous silica NPs (Figure 3 of
main text).
Additional file 2: Higher magnification of a boxed region from
Additional file 1.
Additional file 3: Further EM images of A549 cell after 30 min with
100 μg/ml silica NPs at 4°C shown in Figure 4 of the main text.
Additional file 4: Six figures showing TEM images of A549 cells
after 30 min with and without 100 μg/ml silica NP exposures at 4°C
and 37°C.
Additional file 5: Additional EM images of A549 cells incubated at
4°C for 30 min with a 100 μg/ml of silica NPs.
Additional file 6: Higher Magnification bright field TEM image and
false colour elemental map of A549 cell incubated at 4°C for 30 min
with a 100 μg/ml of silica nanoparticles.
Additional file 7: Tilt series of TEM bright field images of an A549
cell after 24 h incubation at 37°C with 10 μg/ml amorphous silica
nanoparticles (Figure 3 of the main text). This tilt series confirms that
the silica particles are located within the cell.
Additional file 8: Tilt series of higher magnification of the boxed
region in Additional file 1. This tilt series confirms that the silica
particles are located within the cytoplasm of the cell without membrane
encapsulation and are not just on the surface of the ultra-thin section.
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